You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Bevacizumab for Recurrent Glioblastoma Multiforme (GBM)

ID: CED 19 Jul 2010
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
J. Perry, D. Macdonald, A.E. Haynes